AG˹ٷ

STOCK TITAN

[Form 4] American International Group, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Synopsys, Inc. (SNPS) filed an 8-K to disclose that the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) has rescinded the export restrictions that were imposed on certain Synopsys products sold into China on May 29, 2025. The rescission is effective immediately as of July 2, 2025.

The company states it is "working to restore access" for Chinese customers to the previously restricted products and is still evaluating how the temporary restrictions may affect its business, operating results, and overall financial condition. No quantitative impact or guidance revisions were provided in the filing. Management reminds investors that forward-looking statements are subject to risks and uncertainties disclosed in prior SEC reports.

While the 8-K contains no earnings data, the lifting of restrictions removes a potential headwind to Synopsys� sales in a strategically important market. The filing does not mention any conditions, penalties, or ongoing limitations attached to the BIS decision. The company has not updated its outlook and expressly disclaims any obligation to do so after July 2, 2025.

Synopsys, Inc. (SNPS) ha depositato un modulo 8-K per comunicare che il Bureau of Industry and Security (BIS) del Dipartimento del Commercio degli Stati Uniti ha revocato le restrizioni all'esportazione imposte su alcuni prodotti Synopsys venduti in Cina il 29 maggio 2025. La revoca è efficace immediatamente a partire dal 2 luglio 2025.

L'azienda dichiara di essere "al lavoro per ripristinare l'accesso" per i clienti cinesi ai prodotti precedentemente soggetti a restrizioni e sta ancora valutando come tali limitazioni temporanee possano influenzare il suo business, i risultati operativi e la situazione finanziaria complessiva. Nel documento non sono stati forniti dati quantitativi o revisioni delle previsioni. La direzione ricorda agli investitori che le dichiarazioni previsionali sono soggette a rischi e incertezze già indicati in precedenti rapporti SEC.

Anche se il modulo 8-K non contiene dati sugli utili, la rimozione delle restrizioni elimina un potenziale ostacolo alle vendite di Synopsys in un mercato strategicamente importante. Il documento non menziona condizioni, penalità o limitazioni in corso collegate alla decisione del BIS. L’azienda non ha aggiornato le sue previsioni e dichiara esplicitamente di non avere alcun obbligo di farlo dopo il 2 luglio 2025.

Synopsys, Inc. (SNPS) presentó un formulario 8-K para informar que la Oficina de Industria y Seguridad (BIS) del Departamento de Comercio de EE.UU. ha revocado las restricciones de exportación impuestas a ciertos productos de Synopsys vendidos en China el 29 de mayo de 2025. La revocación entra en vigor de inmediato a partir del 2 de julio de 2025.

La compañía indica que está "trabajando para restaurar el acceso" a los productos previamente restringidos para sus clientes chinos y aún está evaluando cómo estas restricciones temporales podrían afectar su negocio, resultados operativos y situación financiera general. No se proporcionaron impactos cuantitativos ni revisiones de las previsiones en el informe. La dirección recuerda a los inversores que las declaraciones prospectivas están sujetas a riesgos e incertidumbres divulgados en informes anteriores a la SEC.

Aunque el 8-K no contiene datos sobre ganancias, el levantamiento de las restricciones elimina un posible obstáculo para las ventas de Synopsys en un mercado estratégicamente importante. El informe no menciona condiciones, sanciones o limitaciones vigentes relacionadas con la decisión del BIS. La empresa no ha actualizado sus perspectivas y declara expresamente que no tiene obligación de hacerlo después del 2 de julio de 2025.

Synopsys, Inc. (SNPS)� 2025� 5� 29� 중국� 판매� 일부 Synopsys 제품� 대� 미국 상무부 산업안전�(BIS)� 부과한 수출 제한� 철회했다� 사실� 공개하기 위해 8-K 보고서를 제출했습니다. 철회� 2025� 7� 2일부� 즉시 발효됩니�.

회사� 중국 고객� 이전� 제한되었� 제품� 다시 접근� � 있도� "복구 작업 �"이며, 이러� 임시 제한� 사업, 운영실적 � 전반적인 재무 상태� 미칠 영향� 아직 평가 중이라고 밝혔습니�. 보고서에� 정량� 영향이나 지� 수정 내용은 포함되지 않았습니�. 경영진은 투자자들에게 미래 예측 진술� 이전 SEC 보고서에� 공개� 위험� 불확실성� 영향� 받을 � 있음� 상기시켰습니�.

8-K 보고서에� 수익 데이터가 없지�, 제한 해제� 전략적으� 중요� 시장에서 Synopsys� 매출� 대� 잠재� 장애물을 제거합니�. 보고서에� BIS 결정� 따른 조건, 벌칙 또는 지속적� 제한 사항� 언급되어 있지 않습니다. 회사� 전망� 업데이트하지 않았으며 2025� 7� 2� 이후에도 이를 � 의무가 없음� 명확� 밝혔습니�.

Synopsys, Inc. (SNPS) a déposé un formulaire 8-K pour divulguer que le Bureau of Industry and Security (BIS) du Département du Commerce des États-Unis a éDZé les restrictions à l'exportation imposées sur certains produits Synopsys vendus en Chine le 29 mai 2025. La révocation est effective immédiatement à compter du 2 juillet 2025.

L'entreprise indique qu'elle « travaille à rétablir l'accès » pour les clients chinois aux produits précédemment restreints et évalue encore comment ces restrictions temporaires pourraient affecter ses activités, ses résultats opérationnels et sa situation financière globale. Aucun impact quantitatif ni révision des prévisions n'a été fourni dans le dépôt. La direction rappelle aux investisseurs que les déclarations prospectives sont soumises à des risques et incertitudes divulgués dans les rapports antérieurs à la SEC.

Bien que le 8-K ne contienne pas de données sur les bénéfices, la levée des restrictions supprime un obstacle potentiel aux ventes de Synopsys sur un marché stratégiquement important. Le dépôt ne mentionne aucune condition, pénalité ou limitation en cours liée à la décision du BIS. L'entreprise n'a pas mis à jour ses perspectives et décline expressément toute obligation de le faire après le 2 juillet 2025.

Synopsys, Inc. (SNPS) hat eine 8-K-Meldung eingereicht, um bekanntzugeben, dass das Bureau of Industry and Security (BIS) des US-Handelsministeriums die am 29. Mai 2025 verhängten Exportbeschränkungen für bestimmte Synopsys-Produkte, die nach China verkauft wurden, aufgehoben hat. Die Aufhebung tritt mit sofortiger Wirkung ab dem 2. Juli 2025 in Kraft.

Das Unternehmen erklärt, es arbeite daran, chinesischen Kunden den Zugang zu den zuvor eingeschränkten Produkten wieder zu ermöglichen und bewertet noch, wie sich die temporären Beschränkungen auf das Geschäft, die Betriebsergebnisse und die finanzielle Gesamtsituation auswirken könnten. Im Bericht wurden keine quantitativen Auswirkungen oder Prognoseanpassungen angegeben. Das Management erinnert Investoren daran, dass zukunftsgerichtete Aussagen Risiken und Unsicherheiten unterliegen, die in früheren SEC-Berichten offengelegt wurden.

Obwohl die 8-K-Meldung keine Gewinnzahlen enthält, beseitigt die Aufhebung der Beschränkungen ein potenzielles Hindernis für Synopsys� Umsatz in einem strategisch wichtigen Markt. Im Bericht werden keine Bedingungen, Strafen oder laufenden Beschränkungen im Zusammenhang mit der BIS-Entscheidung erwähnt. Das Unternehmen hat seine Prognose nicht aktualisiert und weist ausdrücklich darauf hin, dass keine Verpflichtung besteht, dies nach dem 2. Juli 2025 zu tun.

Positive
  • Immediate lifting of BIS export restrictions removes a significant regulatory barrier to selling Synopsys products in China.
  • Ability to restore product access can help recover any deferred sales and stabilize regional revenue contribution.
Negative
  • Ongoing assessment indicates unresolved uncertainty regarding the financial impact of the prior five-week restriction period.
  • Geopolitical and regulatory risks remain, as BIS retains authority to re-impose controls without advance notice.

Insights

TL;DR: BIS rescission re-opens China sales channel; positive for Synopsys� EDA revenue trajectory.

The swift reversal of the May 29 restrictions eliminates a key regulatory overhang that could have curtailed growth in China—an important region for electronic design automation (EDA) demand. Although no revenue figures are given, past disclosures identify Asia-Pacific as a double-digit percentage of total sales; regaining full export ability should stabilize that contribution. Investors should monitor how quickly Synopsys reinstates product access and whether any backlog developed during the five-week ban converts to revenue in upcoming quarters. The absence of new conditions suggests low operational friction, but geopolitical risk remains a recurring theme for U.S. semiconductor tool vendors.

TL;DR: Regulatory threat eased but geopolitical risk persists; watch for future export-control volatility.

The rescinded restrictions materially reduce near-term compliance risk and potential revenue loss. However, Synopsys� acknowledgement that it is "continuing to assess" impact highlights residual uncertainty: (1) sales pipelines may have been disrupted; (2) customers could seek alternatives; and (3) BIS can re-impose controls with little notice. While today’s event is positive, investors should continue to apply a geopolitical risk discount when valuing long-term China exposure.

Synopsys, Inc. (SNPS) ha depositato un modulo 8-K per comunicare che il Bureau of Industry and Security (BIS) del Dipartimento del Commercio degli Stati Uniti ha revocato le restrizioni all'esportazione imposte su alcuni prodotti Synopsys venduti in Cina il 29 maggio 2025. La revoca è efficace immediatamente a partire dal 2 luglio 2025.

L'azienda dichiara di essere "al lavoro per ripristinare l'accesso" per i clienti cinesi ai prodotti precedentemente soggetti a restrizioni e sta ancora valutando come tali limitazioni temporanee possano influenzare il suo business, i risultati operativi e la situazione finanziaria complessiva. Nel documento non sono stati forniti dati quantitativi o revisioni delle previsioni. La direzione ricorda agli investitori che le dichiarazioni previsionali sono soggette a rischi e incertezze già indicati in precedenti rapporti SEC.

Anche se il modulo 8-K non contiene dati sugli utili, la rimozione delle restrizioni elimina un potenziale ostacolo alle vendite di Synopsys in un mercato strategicamente importante. Il documento non menziona condizioni, penalità o limitazioni in corso collegate alla decisione del BIS. L’azienda non ha aggiornato le sue previsioni e dichiara esplicitamente di non avere alcun obbligo di farlo dopo il 2 luglio 2025.

Synopsys, Inc. (SNPS) presentó un formulario 8-K para informar que la Oficina de Industria y Seguridad (BIS) del Departamento de Comercio de EE.UU. ha revocado las restricciones de exportación impuestas a ciertos productos de Synopsys vendidos en China el 29 de mayo de 2025. La revocación entra en vigor de inmediato a partir del 2 de julio de 2025.

La compañía indica que está "trabajando para restaurar el acceso" a los productos previamente restringidos para sus clientes chinos y aún está evaluando cómo estas restricciones temporales podrían afectar su negocio, resultados operativos y situación financiera general. No se proporcionaron impactos cuantitativos ni revisiones de las previsiones en el informe. La dirección recuerda a los inversores que las declaraciones prospectivas están sujetas a riesgos e incertidumbres divulgados en informes anteriores a la SEC.

Aunque el 8-K no contiene datos sobre ganancias, el levantamiento de las restricciones elimina un posible obstáculo para las ventas de Synopsys en un mercado estratégicamente importante. El informe no menciona condiciones, sanciones o limitaciones vigentes relacionadas con la decisión del BIS. La empresa no ha actualizado sus perspectivas y declara expresamente que no tiene obligación de hacerlo después del 2 de julio de 2025.

Synopsys, Inc. (SNPS)� 2025� 5� 29� 중국� 판매� 일부 Synopsys 제품� 대� 미국 상무부 산업안전�(BIS)� 부과한 수출 제한� 철회했다� 사실� 공개하기 위해 8-K 보고서를 제출했습니다. 철회� 2025� 7� 2일부� 즉시 발효됩니�.

회사� 중국 고객� 이전� 제한되었� 제품� 다시 접근� � 있도� "복구 작업 �"이며, 이러� 임시 제한� 사업, 운영실적 � 전반적인 재무 상태� 미칠 영향� 아직 평가 중이라고 밝혔습니�. 보고서에� 정량� 영향이나 지� 수정 내용은 포함되지 않았습니�. 경영진은 투자자들에게 미래 예측 진술� 이전 SEC 보고서에� 공개� 위험� 불확실성� 영향� 받을 � 있음� 상기시켰습니�.

8-K 보고서에� 수익 데이터가 없지�, 제한 해제� 전략적으� 중요� 시장에서 Synopsys� 매출� 대� 잠재� 장애물을 제거합니�. 보고서에� BIS 결정� 따른 조건, 벌칙 또는 지속적� 제한 사항� 언급되어 있지 않습니다. 회사� 전망� 업데이트하지 않았으며 2025� 7� 2� 이후에도 이를 � 의무가 없음� 명확� 밝혔습니�.

Synopsys, Inc. (SNPS) a déposé un formulaire 8-K pour divulguer que le Bureau of Industry and Security (BIS) du Département du Commerce des États-Unis a éDZé les restrictions à l'exportation imposées sur certains produits Synopsys vendus en Chine le 29 mai 2025. La révocation est effective immédiatement à compter du 2 juillet 2025.

L'entreprise indique qu'elle « travaille à rétablir l'accès » pour les clients chinois aux produits précédemment restreints et évalue encore comment ces restrictions temporaires pourraient affecter ses activités, ses résultats opérationnels et sa situation financière globale. Aucun impact quantitatif ni révision des prévisions n'a été fourni dans le dépôt. La direction rappelle aux investisseurs que les déclarations prospectives sont soumises à des risques et incertitudes divulgués dans les rapports antérieurs à la SEC.

Bien que le 8-K ne contienne pas de données sur les bénéfices, la levée des restrictions supprime un obstacle potentiel aux ventes de Synopsys sur un marché stratégiquement important. Le dépôt ne mentionne aucune condition, pénalité ou limitation en cours liée à la décision du BIS. L'entreprise n'a pas mis à jour ses perspectives et décline expressément toute obligation de le faire après le 2 juillet 2025.

Synopsys, Inc. (SNPS) hat eine 8-K-Meldung eingereicht, um bekanntzugeben, dass das Bureau of Industry and Security (BIS) des US-Handelsministeriums die am 29. Mai 2025 verhängten Exportbeschränkungen für bestimmte Synopsys-Produkte, die nach China verkauft wurden, aufgehoben hat. Die Aufhebung tritt mit sofortiger Wirkung ab dem 2. Juli 2025 in Kraft.

Das Unternehmen erklärt, es arbeite daran, chinesischen Kunden den Zugang zu den zuvor eingeschränkten Produkten wieder zu ermöglichen und bewertet noch, wie sich die temporären Beschränkungen auf das Geschäft, die Betriebsergebnisse und die finanzielle Gesamtsituation auswirken könnten. Im Bericht wurden keine quantitativen Auswirkungen oder Prognoseanpassungen angegeben. Das Management erinnert Investoren daran, dass zukunftsgerichtete Aussagen Risiken und Unsicherheiten unterliegen, die in früheren SEC-Berichten offengelegt wurden.

Obwohl die 8-K-Meldung keine Gewinnzahlen enthält, beseitigt die Aufhebung der Beschränkungen ein potenzielles Hindernis für Synopsys� Umsatz in einem strategisch wichtigen Markt. Im Bericht werden keine Bedingungen, Strafen oder laufenden Beschränkungen im Zusammenhang mit der BIS-Entscheidung erwähnt. Das Unternehmen hat seine Prognose nicht aktualisiert und weist ausdrücklich darauf hin, dass keine Verpflichtung besteht, dies nach dem 2. Juli 2025 zu tun.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cole James Jr.

(Last) (First) (Middle)
C/O AMERICAN INTERNATIONAL GROUP, INC.
1271 AVE OF THE AMERICAS

(Street)
NEW YORK NY 10020-1304

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AMERICAN INTERNATIONAL GROUP, INC. [ AIG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock Unit (1) 07/01/2025 A 85(1) (1) (1) Common Stock 85 (1) 16,444(2) D
Explanation of Responses:
1. This award represents dividend equivalent rights in the form of deferred stock units ("DSUs") that are related to the DSUs previously awarded to the reporting person under the American International Group, Inc. ("AIG") 2013 and 2021 Omnibus Incentive Plans (the "2013 and 2021 Plans") as compensation for service as a non-employee director. Under such plans and the related award agreements, these DSUs -- along with the underlying previously awarded DSUs -- will be settled in shares of AIG common stock on a 1-to-1 basis on the last trading day of the month in which the director's service on the Board of Directors ends, unless the director has elected to defer the vesting date.
2. Reflects DSUs previously granted pursuant to the 2013 and 2021 Plans.
/s/ Christina Banthin, by POA from James Cole, Jr. 07/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Synopsys (SNPS) announce in its July 2, 2025 8-K?

BIS rescinded export restrictions on Synopsys products for China, effective immediately.

When were the original export restrictions imposed?

The restrictions were communicated to Synopsys on May 29, 2025.

Does the filing provide updated financial guidance?

No. Synopsys only states it is assessing the impact and did not revise guidance.

What is Synopsys doing following the rescission?

The company is working to restore access to the previously restricted products for Chinese customers.

Are there any remaining conditions from BIS?

The 8-K mentions no ongoing conditions or penalties; the restrictions are lifted "effective immediately."
American Intl Group Inc

NYSE:AIG

AIG Rankings

AIG Latest News

AIG Latest SEC Filings

AIG Stock Data

48.97B
574.66M
0.33%
95.49%
2.22%
Insurance - Diversified
Fire, Marine & Casualty Insurance
United States
NEW YORK